✦ LIBER ✦

Clinical risk factors for ischemic complications after percutaneous coronary interventions: Results from the EPIC trial

✍ Scribed by Mark C. Thel; Robert M. Califf; James E. Tcheng; Kristina N. Sigmon; A.Michael Lincoff; Eric J. Topol; Stephen G. Ellis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vascular Access Site Complications After

✍ James C. Blankenship MD; Anne S. Hellkamp MS; Frank V. Aguirre MD; S.Lee Demko R 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Risk of Major Complications From Coronar

✍ Stephen E Kimmel; Jesse A Berlin; Sean Hennessy; Brian L Strom; Ronald J Krone; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 218 KB

Risk of Thrombosis With the Use of Sirol

✍ Anthony A. Bavry; Dharam J. Kumbhani; Thomas J. Helton; Deepak L. Bhatt 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Validation of the Mayo Clinic Risk Score

✍ Bryan P. Yan; Nick Andrianopoulos; Thomas J. Kiernan; Andrew E. Ajani; David J. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Comparison of Percutaneous Coronary Inte

✍ White, H. D. 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 446 KB

Benefit of bolus-only platelet glycoprot

✍ Jonathan D. Marmur; Cristina A. Mitre; Elliot Barnathan; Erdal Cavusoglu 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 126 KB